China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

This year, JPM 2026 took place again in San Francisco. Let’s look at predictions and trends forecast for 2026, according to ...

The Administration for a Healthy America is RFK Jr.'s plan to tackle chronic disease, addiction and other persistent problems ...

Aging-focused biotech companies share how they're advancing therapies to slow disease, extend lifespan, and transform medicine.

The United States’ escalation of the Venezuela conflict is more than distant geopolitics. Its effects will be felt across ...

In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead ...

Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...

A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...

A new project seeking to transform the drug delivery process and take projects out of “the valley of death” between aspiration and accomplishment is getting help from La Jolla-based medical research ...